An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects with Intermediate Age-Related Macular Degeneration
Administered By
Awarded By
Contributors
- Cousins, Scott William Principal Investigator
- Mettu, Priyatham S Core PI
Start/End
- September 1, 2016 - August 31, 2021